MALSI+ 2021: The Hub at Warp Speed

From Lab to Jab to Beyond

Conference Agenda

MALSI+ 2021 is the Commonwealth's flagship event connecting scientific innovators, entrepreneurs, business leaders, and investors. This year's exciting agenda focuses on the lightning speed, depth, and breadth of innovation emerging from our research institutions, as demonstrated by the pandemic response.  

Conference Schedule - Thursday, July 22, 2021

9.30am-10.00am  Gather/Network

10.00am-10.45am Panel 1: Investing in Innovation

Panelists representing four distinct categories of investors will share insights on what it takes to gain their attention and what they look for in making a decision to close a deal.

10.45am-12:00 pm Poster pitches/audience voting Submit your pitch here!

12pm-12:45pm Lunch Keynote Speaker: Barbara Fox, CEO, Rheos Medicines

12:45pm-1:45pm Structured and Open Networking/Visits at Marketplace for Innovators Tables

1:45pm-2:00 pm Poster winners announced

2:00pm - 2:45pm Panel 2: Pharma Innovations

Modern Pharma companies rely on external innovation with academic and industry partners to bolster their drug R&D pipelines. This panel features leaders of external innovation in 5 of the top 20 Pharma companies. These influential leaders will discuss their companies' perspectives and priorities regarding external innovation and share insights on how to most effectively interact with their teams.

  • Swarna Balasubramanian, Emerging Innovations Program Lead at AstraZeneca
  • Anjali Kumar, External Innovation Search and Evaluation, Eastern US, Johnson & Johnson Innovation;
  • Lizabeth Leveille, Vice President and Head, Boston & European Innovation Hubs, BD&L at Merck;
  • Wendi Yajnik, Global Head of Academic Partnerships and External Innovation at Novartis Institutes for BioMedical Research.
  • Imran Nasrullah, Vice President & Head, Open Innovation Center North America - East at Bayer Pharmaceuticals (Moderator)

2:45pm Networking

Barbara Fox

Barbara S. Fox, PhD, Chief Executive Officer of Rheos Medicines, will deliver the keynote address on her journey from academic to serial biotech entrepreneur and the lessons she learned along the way.

Dr. Fox has more than 25 years of biopharmaceutical leadership expertise.  Previously, as CEO at Tilos Therapeutics, she led the successful acquisition of the company by Merck in June of 2019. She was also Entrepreneur-in-Residence at Partners Innovation Fund, Founder and CEO of Avaxia Biologics, Founder and Chief Scientific Officer of Recovery Pharmaceuticals, and VP, Discovery and Immunology at ImmuLogic Pharmaceutical Corp. Earlier in her career, she was an Associate Professor of Rheumatology at the University of Maryland School of Medicine.

MALSI + 2021 Sponsors

Platinum: MassBio, Novo Nordisk

Gold: Bayer; Massachusetts Life Science Center; McDermott, Will & Emery; Troutman Pepper

Silver: Burns Levinson, Goldcast

Supporter: Boston Entrepreneur's Network, Eli Lilly & Company, Explora Biolabs, Johnson & Johnson Innovation